in this issue
People & Business :: Earnings/Finance
DSM's earnings beat estimates on strong nutrition result, full-year target maintained
7:28 AM MDT | August 6, 2013 | Ian Young
DSM posted net profits before exceptional items of €141 million in the second quarter of 2013, a 24% increase on the corresponding period of 2012. Sales grew 9% year-on-year (YOY) in the second quarter, to €2.5 billion. DSM's Ebitda rose 19% YOY in the second quarter, to €345 million, exceeding analysts' expectations of €330-335 million, due to acquisitions and strong growth in the company's high-margin nutrition business. The sales figure was broadly in line with analysts' estimates. DSM has built human and animal nutrition into the company's...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee